Study summary · 2025 · Evidence review

The economics of patient-reported mobile monitoring

Patient-reported mobile monitoring showed promising but uncertain economic value.

Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence

Original publication

Active remote monitoring of long-term conditions with mobile devices: a systematic review of cost-effectiveness analyses

Sean P Gavan; Katherine Payne; William G Dixon; Sabine N van der Veer; Alexander C T Tam; Nick Bansback

University of Manchester and NIHR Manchester Biomedical Research Centre; Providence Research Institute and University of British Columbia

npj Digital Medicine · Online: · Issue: 2025

Journal version of record. · Full text consulted.

What was studied

Design
Evidence review
Population
Adults with six types of long-term condition
Sample
7 cost-effectiveness analyses
Intervention
Repeated self-reported responses on smartphones/tablets
Comparator
Relevant alternative care strategies
Follow-up
Trial and model horizons varied
Review search cutoff
2024-11
Setting
Multiple countries

Methods

Systematic appraisal of full economic evaluations.

Findings

Six of seven base-case analyses favored cost-effectiveness, but decision uncertainty was substantial.

Limitations

Only seven analyses qualified. Cost measurement differed, and results were specific to each health system. Measurements requiring additional devices, such as BP cuffs or spirometers, and passive wearable monitoring were excluded.

What this means for care delivery

Use this for symptom-monitoring economics; it cannot directly validate connected BP-cuff programs or Medicare RPM margins.